Pharmaceuticals over the steep price because of its key HIV/Helps drug.
These individuals now face a potentially fatal interruption within their treatment. This cannot continue. Merck needs to lower the cost of Isentress immediately. Advocates from AHF testified before members of the CalPERS Investment Committee about the effect of the high cost of the medication on people with AIDS in California and across the country.S. Section of Health and Human Solutions for first-line treatment.. Pharmaceuticals over the steep price because of its key HIV/Helps drug, Isentress, during the 28th Annual J.P. Morgan Health care Conference in SAN FRANCISCO BAY AREA. Isentress can be an integrase inhibitor originally accepted in October 2007 by the meals and Medication Administration as a salvage therapy for individuals who are resistant to various other AIDS drugs. (more…)